Skip to main content

Table 12 Histopathological findings: summary of neoplastic (benign) or neoplastic (malignant) in female

From: Difference in carcinogenicities of two different vapor grown carbon fibers with different physicochemical characteristics induced by intratracheal instillation in rats

Test article

Nontreatment

Control

MWNT-7

VGCF™-H

Total dose (mg/kg)

  

0.13

0.64

3.2

0.13

0.64

3.2

Number of animals

30

30

30

30

30

30

30

30

Heart

        

Schwannoma, intramural

0

0

0

0

2

0

1

0

Pituitary

[17]b

[21]b

[19]b

[16]b

[13]b

[21]b

[25]b

[21]b

Adenoma, pars distalis

8

12

15

10

7

13

16

10

Adenoma, pars intermedia

0

0

0

0

0

0

0

1

Carcinoma, pars distalis

2

0

1

1

2

1

4

2

Thyroid

[6]b

[3]b

[3]b

[2]b

[3]b

[5]b

[7]b

[5]b

Adenoma, C-cell

4

2

1

2

3

4

5

3

Carcinoma, C-cell

2

1

1

0

0

1

3

1

Adrenal

  

[3]b

[2]b

[1]b

[3]b

[1]b

 

Adenoma, cortical

  

0

0

0

0

1

 

Ganglioneuroma, benign

  

0

1

0

0

0

 

Pheochromocytoma, complex, malignant

  

0

0

1

0

0

 

Pheochromocytoma, malignant

  

1

0

0

0

0

 

Lung/bronchial

        

Epithelioma, non-keratinizing

0

0

0

0

1

0

0

0

Stomach

[1]b

[1]b

[4]b

 

[2]b

[3]b

 

[2]b

Papilloma, squamous cell

0

0

0

 

0

1

 

0

Jejunum

[1]b

 

[1]b

[1]b

   

[1]b

Leiomyosarcoma

0

 

0

1

   

0

Cecum

[1]b

 

[2]b

    

[1]b

Leiomyoma

1

 

0

    

0

Lipoma

0

 

1

    

0

Colon

  

[1]b

  

[1]b

  

Leiomyosarcoma

  

0

  

1

  

Liver

        

Adenoma, hepatocellular

0

1

0

2

2

0

0

3

Carcinoma, hepatocellular

1

0

0

0

0

0

0

0

Cholangiocarcinoma

0

0

0

1

0

1

0

0

Kidney

        

Hemangioma

0

0

0

0

1

0

0

0

Carcinoma

0

0

0

0

0

1

0

0

Urinary bladder

[1]b

 

[2]b

 

[2]b

   

Carcinoma, transitional cell

0

 

0

 

0

   

Prep./ Clit. gland

[4]b

 

[2]b

[5]b

 

[1]b

[3]b

 

Adenoma

2

 

0

0

 

0

2

 

Adenocarcinoma

1

 

2

5

 

1

1

 

Mammary gland

[9]b

[10]b

[11]b

[8]b

[6]b

[14]b

[11]b

[8]b

Adenoma

0

0

1

1

0

1

2

2

Fibroadenoma

4

8

7

7

6

11

9

6

Fibroma

1

1

1

1

0

0

0

0

Adenocarcinoma

0

1

1

1

0

0

0

2

Ovary

[3]b

[1]b

[6]b

[2]b

[1]b

[5]b

[4]b

 

Cystadenoma

0

0

0

0

0

1

0

 

Luteoma

1

0

0

0

0

0

0

 

Tumor, granulosa cell, benign

0

0

0

0

0

0

3

 

Uterus

[8]b

[11]b

[9]b

[6]b

[3]b

[5]b

[8]b

[9]b

Leiomyoma

0

0

1

0

0

0

0

0

Polyp, endometrial stromal

3

5

3

1

1

4

3

6

Polyp, glandular

0

0

2

0

1

0

3

0

Adenocarcinoma

0

2

0

0

0

0

0

0

Leiomyosarcoma

0

0

0

1

0

0

0

0

Malignant schwannoma

0

0

1

0

0

0

0

0

Sarcoma, endometrial stromal

1

0

0

0

0

0

0

0

Skin/subcutis

[3]b

[1]b

[3]b

[1]b

[1]b

[3]b

[2]b

[3]b

Adenoma, sebaceous cell

0

0

0

0

0

0

1

1

Fibroma

1

1

0

0

0

0

0

1

Keratoacanthoma

0

0

0

0

0

0

1

0

Malignant fibrous histiocytoma

0

0

1

0

0

0

0

0

Malignant schwannoma

0

0

0

0

1

0

0

1

Osteosarcoma

0

0

0

1

0

0

0

0

Brain

[5]b

[2]b

[6]b

[2]b

[4]b

[10]b

[10]b

[8]b

Invasion (pituitary: carcinoma pars distalis)

2

0

0

0

2

1

1

2

Spinal cord

[1]b

[2]b

[1]b

     

Astrocytoma, malignant, high grade

0

0

1

     

Astrocytoma, malignant, low grade

0

1

0

     

Abdominal cavity

  

[1]b

 

[1]b

   

Mesothelioma, malignant

  

0

 

1

   

Sarcoma, NOS

  

1

 

0

   

Oral cavity

[1]b

       

Carcinoma, squamous cell

1

       

Trigeminal nerve

     

[1]b

  

Neurofibrosarcoma

     

1

  

All sites

[6]b

[4]b

[6]b

[8]b

[1]b

[7]b

[6]b

[5]b

Histiocytic sarcoma

0

0

1

0

0

0

0

0

Large granular lymphocyte leukemia

4

3

5

4

1

5

4

5

Lymphocytic lymphoma

2

1

0

4

0

2

2

0

Site unknown

     

[1]b

  

Endocrine tumor

     

1

  
  1. Significantly different from the Control group; ##p < 0.01
  2. bNumbers in square bracket are for animals examined microscopically